Solid Tumor Testing Market in the US - Market Analysis and Forecast | Technavio

Technavio has published a new market research report on the solid tumor testing market in the US from 2018-2022. (Graphic: Business Wire)

LONDON--()--Market research firm Technavio has announced the release of their latest report on the solid tumor testing market in the US. This new report will provide expert market insights for the forecast period 2018-2022.

The new report will follow-up on Technavio’s previous report, providing detailed analysis and revenue forecasts for the different market segments, in addition to the competitive vendor landscape, highlighting the key vendors in the market.

The upgraded research report on the solid tumor testing market in the US is an integral part of Technavio’s in-vitro diagnostics portfolio. Technavio covers an extensive range of market research reports on the in-vitro diagnostics market that is witnessing tremendous growth. Some of the topics include tissue diagnostics, cancer diagnostic devices, hemoglobin testing, proteomics.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers

Market at a glance

Solid tumor screening or testing is a medical procedure, which aids in the early detection of cancer by permitting effective treatment measures to avoid the spread of cancerous cells throughout the body. The testing procedure includes testing of samples such as urine, blood, and other bodily substances. Owing to the implementation of the healthcare reform in the US, the number of citizens covered by insurance has increased, and the government has also introduced many reimbursement policies for sample testing. The introduction of such effective reimbursement policies will fuel the adoption of these tests in terms of the volume of the insured patients.

In the previous report, a senior research analyst at Technavio stated, “The increasing use of bench-top mass spectrometer is one of the key drivers for the growth of this market. Mass spectrometry is an advanced instrumentation technology that plays an important role in cancer testing because it relates to an increase in the throughput and coverage of complex proteome or genome analysis. A major advantage of this technology is its ability to give accurate results with a minimal quantity of sample. During the forecast period, it is anticipated that this technology will produce breakthrough advances in diagnosis by the characterization of macromolecules to understand a host of cancers that are difficult to screen and diagnose.”

Technavio’s new report on the solid tumor testing market in the US will evaluate the key geographical regions and their behavior over the past four years, introducing new data and observations and providing new predictions.

Looking for the latest information on the solid tumor testing market in the US? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Detailed analysis at your fingertips

Some of the topics that will be revisited in the new report include:

  • Market size and growth rate through 2022
  • Key factors driving the market growth
  • Competitive landscape and revenue share analysis of the key players
  • Market opportunities and factors hindering growth

Technavio’s report on the solid tumor testing market in the US for the period 2018-2022 is available to order now and will be delivered within one week of purchase.

 

Technavio’s best deals of the month!

Celebrate Earth Day and clean energy with Technavio. Get 30% discount on all Energy reports. Offer valid from 12th March - 18th March.

OR

Get 20% off on all Media and Entertainment Services reports. Offer valid only till the 31st of March.

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

Market research firm Technavio has announced the release of their latest report on the solid tumor testing market in the US for 2018-2022.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com